XML 38 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
Unaudited Pro Forma Interim Financial Information - Nine Months Ended September 30, 2012 and 2011 (Tables)
 9 Months Ended
Sep. 30, 2012
Unaudited Pro Forma Interim Financial Information - Nine Months Ended September 30, 2012 and 2011 [Abstract]  
Unaudited Pro Forma Information
The following unaudited pro forma information gives effect to the acquisition of Cell Targeting Inc., Glycosan BioSystems, Inc. (which occurred in 2011), and XenneX as if the acquisition took place on January 1, 2011.  The pro forma information does not necessarily reflect the results of operations that would have occurred had the entities been a single company during the periods presented.
 
 
 
Nine Months Ended September 30,
 
 
 
2012
 
 
2011
 
 
 
(Unaudited)
 
 
(Unaudited)
 
Revenues, net
 
$
2,984,436
 
 
$
3,285,531
 
 
 
 
 
 
 
 
 
 
Net loss available to common shareholders
 
$
(15,288,233
)
 
$
(11,031,976
)
 
 
 
 
 
 
 
 
 
Net loss per common share – basic and diluted
 
$
(0.31
)
 
$
(0.23
)